AA
Andrew Avarbock
Physician · The Derm Group Llp
Credentials: · · · ·
History
- 2022–Present
The Derm Group Llp
- 2009–2012
Dermatology
- 2008–2009
Preliminary or Transitional Year
Research
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Proceedings of the National Academy of Sciences of the United States of America · 2005 · 230 citations
Biochemistry · 2000 · 92 citations
Biochemistry · 2005 · First of 6 authors · 86 citations
3 papers
2 papers
1 paper
1 paper
1 paper
1 paper · 1 as a fellow
1 paper
- DC
1 paper
